Calretinin is a novel candidate marker for adverse ovarian effects of early life exposure to mixtures of endocrine disruptors in the rat (2020)
Attributed to:
The human fetal liver: development and response to maternal drug use.
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1007/s00204-020-02697-3
PubMed Identifier: 32221642
Publication URI: http://europepmc.org/abstract/MED/32221642
Type: Journal Article/Review
Parent Publication: Archives of Toxicology
Issue: 4
ISSN: 0340-5761